NONCLINICAL STUDIES SUBCOMMITTEE
GUEST PARTICIPANTS FOR NOVEMBER 13, 2001 MEETING:
NCTR COMMITTEE REPRESENTATIVE:
Kenneth R. Tindall, Ph.D.
North Carolina Biotechnology Center
15 T. W. Alexander Dr.
P.O. Box 13547
Research Triangle Park, NC 27709-3547
NCSS ACADEMIC PARTICIPANTS:
Kendall B. Wallace, Ph.D., D.A.B.T.
Professor, Department of Biochemistry
& Molecular Biology
University of Minnesota
School of Medicine
Duluth, MN 55812-2487
INVITED INDUSTRY PARTICIPANTS:
Gordon Holt, Ph.D.
Principal Scientist
Oxford GlycoSciences
4 Sparrow Valley CT
Montgomery Village MD 20886-1265
Lester W. Schwartz, DVM, Ph.D.
Group Director, Clinical, Cellular
and Biochemical Pathology
SmithKline Beecham Pharmaceuticals
Safety Assessment – US
709 Swedeland Road, UE0360
King of Prussia, PA 19406-2799
William D. Kerns DVM, MS, DACVP
Pharma Consulting Inc.
PO Box 322
112 Bolton Road
Harvard, MA 01451
GOVERNMENT PARTICIPANTS:
Thomas Papoian, Ph.D.
FDA/CDER/ORM/ DACADP, HFD-170
Parklawn Bldg 9B-45
5600 Fishers Lane
Rockville, MD 20857
Elizabeth A. Hausner, D.V.M., D.A.V.T.
FDA/CDER/ORM/DCRDP/HFD-110
WOC 2 Building, Room 5060
1451 Rockville Pike
Rockville, MD 20852